Dynamic 3-Dimensional Stress Cardiac Magnetic Resonance Perfusion Imaging Detection of Coronary Artery Disease and Volumetry of Myocardial Hypoenhancement Before and After Coronary Stenting by Manka, Robert et al.
C
p
t
i
s
o
p
F
B
E
A
2
a
Journal of the American College of Cardiology Vol. 57, No. 4, 2011
© 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
PCardiac Imaging
Dynamic 3-Dimensional Stress Cardiac
Magnetic Resonance Perfusion Imaging
Detection of Coronary Artery Disease and Volumetry of
Myocardial Hypoenhancement Before and After Coronary Stenting
Robert Manka, MD,*† Cosima Jahnke, MD,* Sebastian Kozerke, PHD,† Viton Vitanis, MSC,†
Gerard Crelier, PHD,† Rolf Gebker, MD,* Bernhard Schnackenburg, PHD,* Peter Boesiger, PHD,†
Eckart Fleck, MD,* Ingo Paetsch, MD*
Berlin, Germany; and Zurich, Switzerland
Objectives The aim of this study was to establish a new, dynamic 3-dimensional cardiac magnetic resonance (3D-CMR) per-
fusion scan technique exploiting data correlation in k-space and time with sensitivity-encoding and to determine
its value for the detection of coronary artery disease (CAD) and volumetry of myocardial hypoenhancement
(VOLUMEhypo) before and after percutaneous coronary stenting.
Background Dynamic 3D-CMR perfusion imaging might improve detection of myocardial perfusion deficits and could facili-
tate direct volumetry of myocardial hypoenhancement.
Methods In 146 patients with known or suspected CAD, a 3.0-T CMR examination was performed including cine imaging,
3D-CMR perfusion under adenosine stress and at rest followed by delayed enhancement imaging. Quantitative
invasive coronary angiography defined significant CAD (50% luminal narrowing). Forty-eight patients under-
went an identical repeat CMR examination after percutaneous stenting of at least 1 coronary lesion. The 3D-
CMR perfusion scans were visually classified as pathologic if 1 segment showed an inducible perfusion deficit
in the absence of delayed enhancement. The VOLUMEhypo was measured by segmentation of the area of induc-
ible hypoenhancement and normalized to left-ventricular myocardial volume (%VOLUMEhypo).
Results The 3D-CMR perfusion resulted in a sensitivity, specificity, and diagnostic accuracy of 91.7%, 74.3%, and 82.9%,
respectively. Before and after coronary stenting, %VOLUMEhypo averaged to 14.2  9.5% and 3.2  5.2%, re-
spectively, with a relative VOLUMEhypo reduction of 79.4  25.4%. Intrareader and inter-reader reproducibility of
VOLUMEhypo measurements was high (Lin’s concordance correlation coefficient, 0.96 and 0.96, respectively).
Conclusions The 3D-CMR stress perfusion provided high image quality and high diagnostic accuracy for the detection of
significant CAD. The VOLUMEhypo measurements were highly reproducible and allowed for the assessment
of the treatment effect achievable by percutaneous coronary stenting. (J Am Coll Cardiol 2011;57:437–44)
© 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.05.067e
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oardiac magnetic resonance (CMR) imaging offers the
otential to comprehensively assess myocardial function on
he basis of combined cine, stress perfusion, and scar
maging. Stress scintigraphic techniques have been exten-
ively employed to establish the diagnosis of and to predict
utcome across the entire spectrum of patients with sus-
ected or known coronary artery disease (CAD). For
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erlin, Germany; and the †Institute for Biomedical Engineering, University and
TH Zurich, Zurich, Switzerland. Dr. Crelier is an employee of GyroTools LLC.
ll other authors have reported that they have no relationships to disclose. The first
authors contributed equally to this work.r
Manuscript received January 17, 2010; revised manuscript received April 28, 2010,
ccepted May 31, 2010.stimation of ischemic burden a semiquantitative segmental
coring system for perfusion at stress and rest is usually
pplied incorporating the extent and severity of reversible
efects. However, radiation-free determination of myocar-
ial ischemic burden of the entire heart with a high in-plane
patial resolution with volumetric measurements on the
asis of disk summation methods is desirable.
Prior knowledge-driven imaging represents a new CMR
echnique to achieve faster dynamic imaging by means of
educed data acquisition on the basis of exploiting correla-
ions in k-space and time (k-t) (1,2). Such accelerated CMR
maging strategies provide the opportunity of full coverage
f the heart while preserving adequate temporal and spatial
esolution. Consequently, k-t accelerated 2-dimensional
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imaging has recently been intro-
duced as a highly attractive diag-
nostic tool, providing informa-
tion on the presence and
transmurality of myocardial re-
gional hypoperfusion with high
in-plane spatial resolution (typi-
cally 1.4  1.4 mm2) (3,4). Po-
tentially, dynamic 3-dimensional
cardiac magnetic resonance (3D-
CMR) perfusion imaging with
full left ventricular (LV) coverage
might further improve detection
of myocardial perfusion deficits
and has been proposed in a fea-
sibility study (5). In addition,
dynamic 3D-CMR perfusion
imaging with preserved high in-
lane resolution could facilitate direct volumetric measure-
ents of myocardial hypoenhancement without extrapolat-
ng the distribution of hypoperfused regions.
Thus, the objective of this study was to determine the
alue of dynamic 3D-CMR perfusion imaging for the
etection of CAD and volumetry of myocardial hypoen-
ancement before and after percutaneous coronary stenting.
ethods
tudy population. The study was approved by the Charité
nstitutional Review Board. From July 2009 through No-
ember 2009, 146 consecutive patients referred to clinically
ndicated invasive coronary angiography (i.e., evaluation of
hest pain syndromes or dyspnea, formally positive exercise
lectrocardiography, cardiac risk stratification before non-
ardiac surgery) underwent a stress CMR perfusion exam-
nation. All patients gave written informed consent before
MR imaging and were instructed to refrain from caffeine-
ontaining beverages or food, smoking, and antianginal
edication for at least 24 h before the study. Patients were
ligible if they had suspected or known CAD (with or
ithout prior percutaneous revascularization) but were not
onsidered for study inclusion if they had typical contrain-
ications for CMR imaging or administration of adenosine.
ardiovascular risk factors and clinical status were recorded
t the time of CMR stress testing.
In a subgroup of 48 patients, a repeat stress CMR
erfusion examination was performed within 24 h after
ercutaneous stenting of at least 1 significantly obstructive
oronary lesion in an epicardial vessel of 2 mm luminal
iameter.
MR study. The CMR imaging was performed with the
atient in the supine position with a 3.0-T MR scanner
Philips Achieva, Best, the Netherlands) equipped with a
uasar Dual gradient system (40 mT/m; 200 mT/m/ms) and
Abbreviations
and Acronyms
2D  2-dimensional
3D-CMR  3-dimensional
cardiac magnetic
resonance
CAD  coronary artery
disease
DE  delayed enhancement
k-t  k-space and time
LV  left ventricle/
ventricular
TE  echo time
TR  repetition time
VOLUMEhypo  volume of
myocardial
hypoenhancementith Philips software release 2.6.3. A 6-element cardiac syn- rrgy coil was used for signal reception, and cardiac synchroni-
ation was performed with a vector-electrocardiogram.
For the assessment of LV function and wall motion at
est, cine imaging was employed with balanced turbo field
cho sequences with retrospective gating (repetition time
TR]/echo time [TE]/flip angle: 3.3 ms/1.6 ms/40°; 50
hases/cardiac cycle; spatial resolution: 1.5  1.5  8.0
m3) during short repetitive breathholding. Cine scans
ere acquired in 3 short-axis (apical, mid-, and basal
hort-axis views) and 3 long-axis geometries (4-, 2-, and
-chamber views) according to standard definitions.
Subsequently, adenosine infusion (140 g/kg/min) was
tarted, and after at least 3 min of adenosine infusion
D-CMR stress first-pass perfusion imaging (intravenous
olus application of 0.1 mmol/kg of gadopentetate dime-
lumine [Magnevist, Schering, Berlin, Germany]; injection
ate 4.0 ml/s followed by 20 ml saline flush) was performed
n short-axis geometry with full LV coverage. After termi-
ation of adenosine infusion and a 10- to 15-min waiting
eriod for equilibration of the contrast agent within the
yocardium, the identical 3D-CMR perfusion scan was
epeated at rest. After another 10-min waiting period
elayed enhancement (DE) imaging was done in the iden-
ical short-axis geometry used for full coverage of the LV
uring 3D-CMR perfusion imaging with a 3D inversion
repared spoiled gradient-echo sequence (TR/TE/flip an-
le: 3.6 ms/1.8 ms/15°, voxel size 1.6  1.6  10.0 mm3).
he inversion recovery prepulse delay was determined from
Look-Locker sequence and adjusted accordingly (range,
90 to 240 ms).
D-CMR perfusion imaging technique. The 3D-CMR
erfusion imaging protocol consisted of a saturation-
ecovery gradient-echo pulse sequence (TR/TE/flip angle
.8 ms/0.7 ms/15°, saturation prepulse delay 150 ms, partial
ourier acquisition, field of view 350  350 mm, measured
oxel size 2.3  2.3  10.0 mm3 reconstructed to 2.3 
.3  5.0 mm3, number of slices 16). For saturation, a
ailored composite prepulse was implemented to compen-
ate for field inhomogeneity effects in the heart at 3.0-T (6).
he acceleration technique k-t with sensitivity-encoding
as employed to speed up data acquisition by a net factor of
.3, thereby permitting data collection during a 200-ms
indow/cardiac cycle. For image reconstruction, informa-
ion from so-called training data collected together with the
ctual data in each cardiac cycle were used to unfold the
ndersampled 3D perfusion datasets. Image reconstruction
as performed with a previously described algorithm (2).
fter the unfolding procedure the training data were sub-
tituted back into the reconstruction matrix for improved
ata consistency (4).
mage quality. Overall image quality of stress and rest
D-CMR perfusion scans was graded on a scale between 1
nd 4 (1  nondiagnostic, 2  poor, 3  good, 4 
xcellent). In addition, the occurrence of image artifacts was
oted and classified as breathing- or k-t reconstruction-
elated (i.e., image flickering), and the presence of suben-
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January 25, 2011:437–44 Dynamic 3D-CMR Perfusionocardial dark rim artifacts was noted. To compare image
uality with conventionally employed 2D rest and stress
MR perfusion scans at 3.0-T, 150 consecutive cases from
ur routine database were evaluated accordingly (7).
isual assessment of dynamic 3D-CMR stress and rest
erfusion scans. The 3D-CMR perfusion examinations
ere analyzed visually with the observer (Dr. Manka) being
ully blinded to clinical and angiographic patient data. All
hort-axis slices with clearly identifiable LV cavity enhance-
ent during contrast agent first-pass and with 75%
ircumferential LV myocardium were considered (i.e., de-
ending on the size of the heart the most apical slice was
xcluded from the analysis if no blood pool signal/
ndocardial border was present or the most basal slice if the
itral valve annulus was visualized predominantly). These
hort-axis views were then divided in 6 equally distributed
egments and evaluated visually for the presence of inducible
erfusion deficits with the following criteria being rigor-
usly applied: on adenosine 3D-CMR stress perfusion
cans, a regional hypoenhancement in any segment with
25% transmurality persisting for3 consecutive dynamics
ot being visible on the rest perfusion scan and in the
bsence of DE was considered to be pathologic ( inducible
erfusion deficit).
For comparison with a 2D CMR perfusion approach, the
tandardized 3-slice model with equally distributed short-
xis slices covering 16 segments was applied to all 3D-CMR
erfusion datasets (slice 4, 8, and 12), and diagnostic values
esulting from evaluation of these 3 slices only were calcu-
ated on a per patient basis.
olumetry of myocardial hypoenhancement. In the pa-
ient group with CMR stress perfusion examinations before
nd after coronary stenting a volumetric analysis of stress
nducible perfusion deficits was carried out. Volumetry of
D-CMR perfusion datasets was performed with GTVolume
version 1.3.9, GyroTools, Zurich, Switzerland) with the
oftware containing a specifically designed module for myocar-
ial segmentation and calculation of total myocardial hypoen-
ancement (VOLUMEhypo) according to the disk summa-
ion method.
For measurements of VOLUMEhypo the single dynamic
lice images of the stress perfusion scan showing the
aximum extent of regional hypoenhancement during peak
ignal enhancement of remote myocardium were chosen,
nd the observer manually outlined LV endocardial and
picardial borders in all slices. Subsequently, segmentation
f LV myocardium was done on a pixel-by-pixel basis by
djusting the signal-intensity threshold 2 SDs below the
ignal of remote myocardium, and the area of hypoenhance-
ent was measured. Total LV myocardial volume and total
OLUMEhypo (both in ml) were calculated with the disk
ummation method, and total VOLUMEhypo was normal-
zed to LV myocardial volume (%VOLUMEhypo). In case
ubendocardial or transmural scarring was present in corre-
ponding DE images (n  11), the amount of scar was
uantified by manual segmentation with the signal intensity threshold set to 2 SD above the mean signal intensity of a
emote myocardial region and subtracted from VOLUMEhypo,
o identify the amount of inducible ischemia in the border zone
f chronic myocardial infarction only.
etermination of intraobserver and interobserver vari-
bility. In all 48 patients undergoing 3D-CMR perfusion
maging before and after coronary stenting VOLUMEhypo
easurements were carried out as follows: for determination
f intraobserver variability 1 reader (R.M., 4 years expe-
ience in reading 300 stress CMR perfusion studies/year)
epeated the analysis 4 weeks later, and for determination of
nterobserver variability a second reader (I.P., 10 years
xperience in reading 1,000 stress CMR perfusion stud-
es/year) independently performed the evaluation. Both
eaders were fully blinded to clinical and angiographic
atient data.
uantitative coronary angiography. The X-ray coronary
ngiography was performed by standard techniques with a
imultaneous biplane, multidirectional, and isocentric X-ray
ystem. At least 2 orthogonal views of every major coronary
essel and its side branches were acquired. Quantitative
oronary angiography (Philips Inturis CardioView, QCA
ersion 3.3, Pie Medical Imaging, Maastricht, the Nether-
ands) was performed off-line by an independent observer
12 years experience) who was unaware of the results of
MR imaging. Significant CAD was defined as 50%
arrowing of the luminal diameter of at least 1 major
picardial artery with 2 mm diameter.
tatistical analysis. All statistical data analysis was per-
ormed with SPSS for Windows version 17.0.0 (SPSS Inc.,
hicago, Illinois). Continuous variables are expressed as
ean  SD; categorical variables are expressed as propor-
ions. The paired Student t test was used to assess statistical
ignificance of continuous variables. Group differences for
rdinal variables were tested with the Mann-Whitney U or
ilcoxon’s signed-rank test. All tests were 2-tailed; p 
.05 was considered significant.
Sensitivity and specificity with corresponding 95%
onfidence intervals (CIs) were calculated according to
tandard definitions. Intrareader and inter-reader vari-
bility of VOLUMEhypo measurements was investigated
ith Pearson’s correlation and Lin’s concordance correlation
oefficient. The latter was calculated to assess the concor-
ance of continuous data with the following scale to
escribe the strength of agreement: 0.99 indicates almost
erfect agreement; 0.95 to 0.99 indicates substantial agree-
ent; 0.90 to 0.95 indicates moderate agreement; and
0.90 indicates poor agreement. In addition, Bland-
ltman analysis was done to compare VOLUMEhypo mea-
urements; the degree of agreement was determined as
ean absolute difference (bias)  2 SDs of the mean
ifference. Treatment effect was determined with Cohen’s d
ffect size calculated as the difference of the means divided
y the SD with the following scale: d  0.2 indicates small;
 0.5 indicates medium; and d  0.8 indicates largereatment effect.
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atient characteristics. Table 1 provides the clinical base-
ine characteristics of the complete patient population.
mage quality. The 3D-CMR stress and rest perfusion
cans of all 146 patients were of diagnostic image quality
image quality score 2) and thus included in the analysis
Table 2). The mean visual score of 2D stress and rest
MR perfusion scans was 3.4  0.6 and 3.5  0.6,
espectively (p  NS) without significant differences
etween 3D-CMR and 2D CMR perfusion imaging
p  NS). Breathing-related imaging artifacts occurred
n 18 patients (12.3%), k-t reconstruction-related arti-
acts (i.e., image flickering) occurred in 14 (9.6%), and
ubendocardial dark rim artifacts occurred in 12 patients
8.2%). A representative imaging example is given in
igure 1 (see also Online Videos 1 and 2).
iagnostic accuracy. Prevalence of significant CAD was
9.3% (72 of 146 patients). Visual analysis of 3D-CMR
erfusion images yielded a sensitivity, specificity, and diag-
ostic accuracy of 91.7% (95% CI: 84.6 to 98.7), 74.3%
95% CI: 63.7 to 85.0), and 82.9% (95% CI: 76.4 to 89.3),
espectively, for the detection of 50% luminal narrowing
Fig. 2, Online Video 3). Sensitivity for the detection of
ingle- and multi- (i.e., double and triple) vessel disease was
0.9% (40 of 44) and 92.9% (26 of 28), respectively.
When applying the standard 3-slice model to the dy-
amic 3D-CMR perfusion datasets, sensitivity, specificity,
aseline Characteristics of PatientsTable 1 Baseline Characteristics of Patients
Men, n 102 (69.9)
Age, yrs 63 11
Range 20–85
BMI, kg/m2 27.2 3.9
BMI 25 kg/m2 110 (75.3)
Hypertension 122 (83.6)
Diabetes mellitus 32 (21.9)
Hyperlipoproteinemia 105 (71.9)
Cigarette smoking 38 (26.0)
Known CAD 65 (44.5)
Prior myocardial infarction 26 (17.8)
Prior PCI 64 (43.8)
Number of diseased vessels
Single 44 (30.1)
Multiple (double/triple) 28 (19.2)
ata are n (%) or mean  SD.
BMI  body mass index; CAD  coronary artery disease; PCI  percutaneous coronary
ntervention.
Image Quality Scoring of Dynamic 3D-CMR PerfTable 2 Image Quality Scoring of Dynamic 3
4  excellent 3  good
At rest 83 (56.8%) 58 (39.7%
Adenosine stress 75 (51.4%) 65 (44.5%n  146 patients. Data are n (%) or mean  SD.
3D-CMR  3-dimensional cardiac magnetic resonance.nd diagnostic accuracy were 87.5% (95% CI: 79.2 to 95.8),
4.3% (95% CI: 63.7 to 85.0), and 80.8% (95% CI: 74.1 to
7.6) (p  NS). The decrease in sensitivity in comparison
ith 3D-CMR perfusion was the result of 3 patients with
ingle-vessel disease being misclassified as “false-negative.”
ntraobserver and interobserver variability of volumetry
f myocardial hypoenhancement. Intra- and inter-reader
easurements of VOLUMEhypo showed a strong correla-
ion (Pearson’s correlation coefficient, 0.96 and 0.96, respec-
ively, both p  0.001) and substantial concordance (Lin’s
orrelation coefficient, 0.96 [95% CI: 0.94 to 0.98] and 0.96
95% CI: 0.93 to 0.98], respectively).
Corresponding Bland-Altman plots are shown in Figure 3;
ias for intrareader and inter-reader measurements was 0.19 ml
95% CI: 2.59 to 2.89) and 0.14 ml (95% CI: 3.14 to
.86), respectively. A representative imaging example illustrat-
ng segmentation of VOLUMEhypo is shown in Figure 4.
ffect of percutaneous coronary stenting on volume of
yocardial hypoenhancement. Mean VOLUMEhypo in
ercentage of LV myocardium was 14.2  9.5% (range,
.7% to 37.8%) before stenting and 3.2  5.2% (range, 0%
o 28.2%) after stenting (Fig. 5). Relative VOLUMEhypo
eduction averaged to 79.4  25.4% with the following
istribution of the number of patients grouped according to
elative VOLUMEhypo reduction: 100% (n  18), 99% to
5% (n  15), 74% to 50% (n  8), 49% to 25% (n  5),
nd 25% (n  2). Treatment effect was large as estimated
y Cohen’s d (1.2 [95% CI: 1.5 to 3.8]). Online Video 4
hows a representative imaging example before and after
oronary stenting.
iscussion
he present study is the first to assess the diagnostic value of
ynamic 3D-CMR stress perfusion imaging for the detection
f CAD in patients with suspected or known coronary disease
nd to apply volumetric measurement of myocardial hypoen-
ancement before and after percutaneous coronary stenting.
The main findings of our study are: 1) dynamic 3D-
MR stress perfusion imaging could be successfully per-
ormed in a large, consecutive patient population and
esulted in a high percentage of high-quality diagnostic
tudies; 2) the diagnostic value of 3D-CMR stress perfusion
maging is high and within the range of previously reported
ccuracy values on multislice 2D CMR perfusion imaging
8); 3) dynamic 3D-CMR stress perfusion imaging yielded
R Perfusion
Image Quality
2  poor 1  nondiagnostic Mean
5 (3.4%) 0 (0%) 3.5 0.6
6 (4.1%) 0 (0%) 3.5 0.6usionD-CM
)
)
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January 25, 2011:437–44 Dynamic 3D-CMR Perfusionhigh diagnostic value independent of the number of
iseased coronary vessels; 4) volumetry of myocardial hy-
oenhancement can be carried out with high inter- and
ntra-reader reproducibility; and 5) relative reduction of
Figure 1 Dynamic 3D-CMR Perfusion Scans and Invasive X-Ray
(A, B) Dynamic 3-dimensional cardiac magnetic resonance (3D-CMR) perfusion scans
anterior, anteroseptal, and inferoseptal segments with varying transmurality encompas
Invasive X-ray coronary angiogram demonstrating high-grade single-vessel disease of total myocardial hypoenhancement at Day 1 after stenting bas 79.4 25.4% consistent with a large treatment effect in
he current study population.
The impetus for the development and subsequent clinical
esting of a dynamic 3D-CMR stress perfusion technique has
nary Angiogram
adenosine stress (A) and at rest (B). An extensive inducible perfusion deficit in
pical to equatorial slices can be detected (see also Online Videos 1 and 2). (C, D)
anterior descending artery (quantitative coronary angiography stenosis 75%).Coro
during
sing aeen primarily 2-fold: to ensure comprehensive coverage of the
442 Manka et al. JACC Vol. 57, No. 4, 2011
Dynamic 3D-CMR Perfusion January 25, 2011:437–44Figure 2 Dynamic 3D-CMR Stress Perfusion Scan in Double-Vessel CAD
Dynamic 3-dimensional cardiac magnetic resonance stress perfusion scan (A) and corresponding X-ray coronary angiogram (B, C) (double-vessel disease of left anterior
descending and left circumflex coronary arteries, black arrowheads); the resting perfusion scan was normal. Extensive, strictly inducible perfusion deficits in anterior/
anteroseptal and in inferior/inferolateral segments can be appreciated (see also Online Videos 3 and 4).Figure 3 Intrareader and Inter-Reader Agreement for Volumetry of Myocardial Hypoenhancement
Bland-Altman plots demonstrating (A) intra- and (B) inter-reader agreement for volumetry of myocardial hypoenhancement (VOLUME ).hypo
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January 25, 2011:437–44 Dynamic 3D-CMR Perfusioneart with the potential to improve diagnostic accuracy for the
etection of ischemic myocardial regions and to allow direct
olumetric quantification of LV myocardial hypoenhance-
ent. Our results indicate that full spatial coverage of the heart
id not necessarily lead to a significant improvement in
iagnostic accuracy on a per patient basis when aiming at the
etection of perfusion abnormalities associated with the pres-
nce of epicardial coronary stenosis. However, complete visu-
lization of inducible perfusion abnormalities frequently seen
B
A
Figure 4 Segmentation-Based Volumetry of Myocardial Hypoen
(A) Consecutive slices of a dynamic 3-dimensional cardiac magnetic resonance st
of myocardial hypoenhancement (segmented red areas). Volume of myocardial hy
Figure 5 Effect of Coronary Stenting on the Amount
of Stress-Inducible Myocardial Hypoenhancement
Diagram illustrating the effect of percutaneous coronary stenting on
%VOLUMEhypo as assessed by 3-dimensional cardiac magnetic resonance
stress perfusion imaging. Lines track individual patient values before and
after coronary stenting. %VOLUMEhypo  VOLUMEhypo was measured by seg-
mentation of the area of inducible hypoenhancement and normalized to leftan other cardiac disease states (e.g., ventricular hypertrophy,
iabetes, cardiomyopathies) might prove beneficial (9). Rather,
he main advantage of 3D-CMR stress perfusion imaging lies
n its inherent ability to comprehensively quantify myocardial
ypoenhancement without underlying geometric assumptions
bout the distribution of hypoperfused myocardium in the
ntire heart, and our data corroborated the high interreader
nd intrareader reproducibility of volumetric quantification in
atients with CAD. Accordingly, dynamic 3D-CMR stress
erfusion might be considered useful to directly quantify the
fficacy of therapeutic approaches targeted at improved myo-
ardial perfusion. In the present study, primary percutaneous
tenting was chosen to exemplify that 3D-CMR stress perfu-
ion imaging can be used for direct quantification of the effect
ize of myocardial perfusion improvement as indicated by the
eduction of the volume of myocardial hypoenhancement. The
alues for percentage of myocardial hypoenhancement with
D-CMR perfusion were within the range of previously
ublished trials using quantitative single-photon emission
omputed tomography for determination of myocardial isch-
mic burden (10). However, additional studies aiming at a
irect comparison between 3D-CMR and single-photon
mission computed tomography–derived measures of the
mount of hypoperfused myocardium are warranted. Perspec-
ively, taking full advantage of the noninvasiveness of CMR
maging, serial 3D-CMR stress perfusion imaging could po-
entially be employed to measure and compare the efficiency of
ther medical and interventional measures (e.g., gene therapy)
esigned to improve regional myocardial blood flow (11). In
ment
erfusion scan. (B) Identical images illustrating volumetry
ncement was 24% of total myocardium (29.9 of 125.5 ml).hance
ress p
poenhaventricular myocardial volume.
ddition, with myocardial hypoenhancement assessable as a
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Dynamic 3D-CMR Perfusion January 25, 2011:437–44ontinuous parameter a more distinct prognostication and risk
tratification of identifiable patient groups is likely and war-
ants investigation in future studies.
tudy limitations. In the present study, volume of myo-
ardial hypoenhancement was considered indicative of
educed myocardial blood flow associated with the an-
iographically confirmed presence of coronary luminal
arrowing. However, invasive coronary angiography has
een recognized to be of limited value for the character-
zation of the functional severity of coronary luminal
arrowing at intermediate degrees of stenosis and thus
ight be considered a poor indicator of hemodynamically
elevant (i.e., ischemia-producing) coronary disease.
ence, further validation with fractional flow reserve
easurements as the standard of reference is needed.
ssessment of interstudy reproducibility of 3D-CMR
tress perfusion is of critical importance for serial testing
ut remains to be determined. Finally, the present study
as conducted at a single center with an expert group of
hysicians carrying out and interpreting the CMR exam-
nations; thus, future large-scale multicenter trials are
esirable to ultimately define the value of 3D-CMR
erfusion in clinical routine and its usefulness for cardiac
isk stratification or determination of the treatment effect
f anti-ischemic therapies.
onclusions
ynamic 3D-CMR stress perfusion imaging at 3.0-T
roved to be a robust method with consistently high image
uality. In patients with known or suspected CAD dynamic
D-CMR stress perfusion yielded high diagnostic accuracy
or the detection of significant CAD. Volumetry of myo-
ardial hypoenhancement was highly reproducible and al-
owed for the assessment of the treatment effect achievable
y percutaneous coronary stenting. Consequently, dynamic
D-CMR stress perfusion imaging can be regarded as a
owerful, noninvasive diagnostic tool for the detection and
erial quantification of myocardial perfusion abnormalities
uring follow-up of anti-ischemic therapies.
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